Drugs were left out of a 2024 rule streamlining prior authorizations by making decisions electronic and requiring payers to turn them around more quickly. The Trump administration is looking to address that gap.
Healthcare Dive published a clinical update in Research Highlights on 13 Apr 2026.
The item focuses on CMS proposes new deadlines for prior authorizations for drugs.
Review the original article for the full source wording and details.